ArticleJournal of experimental & clinical cancer research : CR2024

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.

Baoyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.